2.36
price down icon7.45%   -0.19
 
loading
전일 마감가:
$2.55
열려 있는:
$2.53
하루 거래량:
116.38K
Relative Volume:
0.49
시가총액:
$56.52M
수익:
$48.20M
순이익/손실:
$-35.05M
주가수익비율:
-1.5058
EPS:
-1.5673
순현금흐름:
$-13.02M
1주 성능:
-38.70%
1개월 성능:
-25.32%
6개월 성능:
+118.52%
1년 성능:
-13.24%
1일 변동 폭
Value
$2.321
$2.55
1주일 범위
Value
$2.225
$4.00
52주 변동 폭
Value
$1.06
$5.22

Celularity Inc Stock (CELU) Company Profile

Name
명칭
Celularity Inc
Name
전화
(908) 768-2170
Name
주소
170 PARK AVE, FLORHAM PARK
Name
직원
123
Name
트위터
Name
다음 수익 날짜
2024-11-04
Name
최신 SEC 제출 서류
Name
CELU's Discussions on Twitter

CELU을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CELU
Celularity Inc
2.36 61.07M 48.20M -35.05M -13.02M -1.5673
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Celularity Inc Stock (CELU) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-01-30 다운그레이드 Morgan Stanley Equal-Weight → Underweight
2022-12-22 다운그레이드 Oppenheimer Outperform → Perform
2022-06-22 개시 H.C. Wainwright Buy
2022-04-06 다운그레이드 Truist Buy → Hold
2022-01-28 개시 Oppenheimer Outperform
2021-11-24 개시 Morgan Stanley Equal-Weight
모두보기

Celularity Inc 주식(CELU)의 최신 뉴스

pulisher
Sep 04, 2025

Celularity Inc. Equity Warrant stock trend outlook and recovery path2025 Performance Recap & Real-Time Volume Analysis - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Chart based analysis of Celularity Inc. trendsWeekly Trend Report & Low Drawdown Investment Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Multi asset correlation models including Celularity Inc.2025 Pullback Review & Expert Approved Momentum Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What is the long term forecast for Celularity Inc. Equity Warrant stock2025 Investor Takeaways & Capital Protection Trading Alerts - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

What earnings revisions data tells us about Celularity Inc. Equity Warrant2025 Trading Recap & AI Enhanced Trading Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Celularity Achieves Nasdaq Compliance with Recent Filing - The Globe and Mail

Sep 04, 2025
pulisher
Sep 04, 2025

Published on: 2025-09-04 05:10:48 - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Celularity Inc. Equity Warrant stock trend forecastTrade Exit Report & Fast Exit Strategy with Risk Control - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What makes Celularity Inc. Equity Warrant stock price move sharply2025 Price Momentum & Free Expert Approved Momentum Trade Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Real time scanner hits for Celularity Inc. explainedAnalyst Downgrade & Weekly High Momentum Picks - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Celularity Fulfills Nasdaq Listing Rule, Retires $41.6mln Debt, and Unveils Growth Plans - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Is it time to cut losses on Celularity Inc. Equity WarrantShare Buyback & Daily Volume Surge Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can machine learning forecast Celularity Inc. recoveryShort Setup & Capital Efficient Trade Techniques - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Celularity Inc. being accumulated by smart money2025 Big Picture & Proven Capital Preservation Methods - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Will Celularity Inc. Equity Warrant see short term momentumBuy Signal & Community Verified Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Celularity Inc. continue delivering strong returns2025 Analyst Calls & Verified Momentum Watchlists - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Using data filters to optimize entry into Celularity Inc.Earnings Growth Report & Low Drawdown Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using AI based signals to follow Celularity Inc.2025 Market Overview & Verified Swing Trading Watchlists - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Order flow analysis tools used on Celularity Inc.CPI Data & Fast Gaining Stock Strategy Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Sentiment Recap: Can Celularity Inc. Equity Warrant outperform under higher oil pricesPortfolio Value Report & Reliable Breakout Stock Forecasts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Celularity Announces Filing of Form 10-Q Quarterly Reports for the First Quarter and the Second Quarter 2025, Confirmation of Nasdaq Listing Rule 5250(c)(1) Compliance - Stock Titan

Sep 03, 2025
pulisher
Sep 03, 2025

Celularity Files Q1 and Q2 2025 Form 10-Q Reports, Confirms Nasdaq Listing Rule Compliance - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Celularity Announces Filing of Form 10-Q Quarterly Reports - GlobeNewswire

Sep 03, 2025
pulisher
Sep 03, 2025

Celularity Reports Q1 and Q2 Earnings, Complies with Nasdaq Listing Rules. - AInvest

Sep 03, 2025
pulisher
Sep 03, 2025

Real time social sentiment graph for Celularity Inc.Earnings Trend Report & Safe Capital Allocation Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Analyzing recovery setups for Celularity Inc. investorsMarket Trend Summary & Reliable Entry Point Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Risk vs reward if holding onto Celularity Inc. Equity WarrantPortfolio Profit Report & Fast Gain Swing Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What recovery options are there for Celularity Inc.Analyst Downgrade & Free Long-Term Investment Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Celularity Inc. reversing from oversold territoryJuly 2025 Spike Watch & Daily Chart Pattern Signal Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is a relief rally coming for Celularity Inc. Equity Warrant holdersEarnings Risk Report & Long-Term Investment Growth Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What’s Celularity Inc. Equity Warrant’s historical returnSwing Trade & Smart Money Movement Tracker - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Celularity Inc. Building a Base Near Support getLinesFromResByArray error: size == 0 - thegnnews.com

Sep 03, 2025
pulisher
Sep 03, 2025

What is the earnings history of Celularity Inc. Equity WarrantDollar Strength & High Win Rate Trade Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

How Celularity Inc. stock performs during market volatility2025 Pullback Review & Fast Entry High Yield Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time scanner hits for Celularity Inc. Equity Warrant explainedWeekly Profit Analysis & Verified Swing Trading Watchlists - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

How hedge fund analytics apply to Celularity Inc. stockMarket Sentiment Report & Verified Swing Trading Watchlist - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Applying chart zones and confluence areas to Celularity Inc.Weekly Profit Analysis & Growth Focused Investment Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Applying Wyckoff theory to Celularity Inc. stockJuly 2025 PreEarnings & Capital Efficient Trade Techniques - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

What moving averages say about Celularity Inc. Equity WarrantJuly 2025 Movers & Precise Swing Trade Entry Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Celularity Inc. a strong candidate for buy and holdJuly 2025 Volume & Weekly High Return Stock Forecasts - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Understanding Celularity Inc.’s price movementQuarterly Growth Report & Free Expert Verified Stock Movement Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Has Celularity Inc. found a price floor2025 AllTime Highs & Daily Volume Surge Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Using Ichimoku Cloud for Celularity Inc. Equity Warrant technicalsMarket Trend Review & High Conviction Buy Zone Picks - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Celularity Inc. shares drop 40.36% intraday after reporting a 53% decline in Q2 revenue and a 278% increase in net loss. - AInvest

Sep 02, 2025
pulisher
Sep 02, 2025

Nasdaq Down 1%; Signet Jewelers Earnings Top Views - Benzinga

Sep 02, 2025
pulisher
Sep 02, 2025

What institutional flow reveals about Celularity Inc.July 2025 Rallies & Low Drawdown Investment Strategies - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Celularity Inc. stock a top performer YTD2025 Market WrapUp & Verified Momentum Watchlists - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

Combining price and volume data for Celularity Inc. Equity WarrantMarket Growth Report & Reliable Price Action Trade Plans - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Statistical indicators supporting Celularity Inc. Equity Warrant’s strength2025 Earnings Surprises & Daily Stock Trend Reports - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Can volume confirm reversal in Celularity Inc. Equity WarrantJuly 2025 Gainers & Stepwise Trade Signal Implementation - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Is Celularity Inc. stock a good dividend stockJuly 2025 Market Mood & Fast Gain Stock Tips - khodrobank.com

Sep 02, 2025

Celularity Inc (CELU) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

Celularity Inc 주식 (CELU) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
Hariri Robert J
Chief Executive Officer
Apr 13 '25
Option Exercise
0.00
3,281
0
21,482
Haines John R
Senior Exec Vice President
Apr 13 '25
Option Exercise
0.00
1,641
0
29,698
Beers David C
Chief Financial Officer
Apr 13 '25
Option Exercise
0.00
1,025
0
18,561
Brigido Stephen
Pres., Functional Regeneration
Feb 17 '25
Option Exercise
0.00
10,000
0
11,641
Beers David C
Chief Financial Officer
Feb 17 '25
Option Exercise
0.00
12,500
0
21,932
Haines John R
Senior Exec Vice President
Feb 17 '25
Option Exercise
0.00
20,000
0
35,092
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
자본화:     |  볼륨(24시간):